02/03/2021
Discussion with Dr. Scott Macrae talking about the SimVis technology
Please, check the interesting talk and discussion with Dr. Scott Macrae talking about the SimVis technology and his experience using it here
26/11/2020
2Eyes Vision closed a EUR 1.34m funding round
Glad to announce that 2Eyes Vision closed a 1.34M€ funding round led by Bullnet Capital,  also subscribed by Centro para el Desarrollo Tecnológico e Industrial (CDTI) […]
20/10/2020
Our co-founder Susana Marcos presented the SimVis technology at the Ophthalmology Futures European Forum
Check out the presentation here
02/10/2020
Our latest paper on the SimVis technology gets published
Check out HERE our latest paper on the SimVis technology, showing how visual simulators allow patients to experience multifocal vision non-invasively.
02/10/2020
Optimoda interviews our CEO, Carlos Dorronsoro
We are extremely proud to announce that our co-founder Carlos Dorronsoro Díaz has recently joined us as CEO. Carlos has more than 20 years of experience in technology […]
31/07/2020
WE ARE HIRING! Looking for a Product Engineer
2Eyes Vision is focused on the design, development and commercialization of innovative ophthalmic technologies that improve the daily routine of eye care practitioners and help to […]
30/07/2020
WE ARE HIRING! Looking for a Clinical Development Optometrist
2Eyes Vision is focused on the design, development and commercialization of innovative ophthalmic technologies that improve the daily routine of eye care practitioners and help to […]
03/06/2020
IMCUSTOMEYE develops new image techniques for ocular pathology ‘Á la carte’ treatment
2Eyes Vision participates in the IMCUSTOMEYE project, coordinated by the VioBio lab, from the CSIC´s Optics Institute, and funded by the European Commision´s ‘Horizont 2020 Programme’, […]
24/02/2020
Transforming the Ophthalmic Surgery Guessing Game
In most clinics, surgeons are faced with a big issue: the refractive surgery guessing game. That’s because they rely on self-reporting from patients to determine daily focusing […]